Cryoballoon ablation for persistent atrial fibrillation in patients without left atrial fibrosis.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
07 2019
Historique:
received: 21 02 2019
revised: 28 03 2019
accepted: 28 03 2019
pubmed: 3 4 2019
medline: 15 9 2020
entrez: 3 4 2019
Statut: ppublish

Résumé

The role of cryoballoon (CB) pulmonary vein isolation (PVI) for patients with persistent atrial fibrillation (AF) is controversial, since long-term success can be poor. We performed left atrial voltage mapping before CB PVI and determined AF-free survival depending on the extent of low-voltage areas (LVAs). We consecutively enrolled 60 patients with persistent AF (average age, 60.6 ± 12.9 years; CHA In patients with persistent AF undergoing CB PVI, the extent of left atrial LVAs predicts an AF-free survival. CB PVI seems to be a highly effective treatment for patients with persistent AF without atrial fibrosis.

Identifiants

pubmed: 30938897
doi: 10.1111/jce.13936
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

999-1004

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : #01ZX1407B
Pays : International
Organisme : German Federal Ministry of Education and Research (BMBF)
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Michael Gramlich (M)

Department of Invasive Electrophysiology, RWTH Aachen, Aachen, Germany.
Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany.

Carole Maleck (C)

Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany.

Jonathan Marquardt (J)

Department of Invasive Electrophysiology, RWTH Aachen, Aachen, Germany.

Martin Duckheim (M)

Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany.

Fabian Stimpfle (F)

Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany.

David Heinzmann (D)

Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany.

Christian Scheckenbach (C)

Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany.

Meinrad Gawaz (M)

Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany.

Jürgen Schreieck (J)

Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany.

Peter Seizer (P)

Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH